Swiss Pharmaceuticals & Biotech Profitable Climbers

Newron Pharmaceuticals

Market Cap: CHF 385.5m

A biopharmaceutical company, discovers and develops novel therapies for patients with diseases of the central and peripheral nervous system in Italy and the United States.

Cosmo Pharmaceuticals

Market Cap: CHF 1.9b

Focuses on the development and commercialization products for gastroenterology, dermatology, and healthtech worldwide.

Sandoz Group

Market Cap: CHF 28.9b

Develops, manufactures, and markets generic pharmaceuticals and biosimilars worldwide.

SKAN Group

Market Cap: CHF 1.2b

Provides isolators, cleanroom devices, and decontamination processes for pharmaceutical and chemical industries in Europe, the Americas, Asia, and internationally.

Galderma Group

Market Cap: CHF 36.6b

Operates as a dermatology company worldwide.

Basilea Pharmaceutica

Market Cap: CHF 661.3m

A Swiss commercial-stage biotech company focused on developing and commercializing treatments for severe bacterial and fungal infections.